Terns Pharmaceuticals Inc. was acquired by Merck & Co. in May 2026. TERN no longer trades, so its trials are no longer stock catalysts and are left off the trial calendar. The records below are kept for reference; the programs now belong to Merck & Co., and their dates may not have been updated since.
Clinical trial readout dates for Terns Pharmaceuticals Inc., compiled from
ClinicalTrials.gov, alongside the SEC filings where results are announced.
The next expected readout is November 2029.